Methods: A total of 5000 students from Shandong University in China were asked in January-May 2012 to complete questionnaires, including the Rome III questionnaire, hospital anxiety and depression scale, and negative

life events scale. Results: Based on the 4638 students who completed the questionnaire, the prevalence of functional dyspepsia, irritable bowel syndrome and functional constipation in find more college and university students of North China worked out to be 9.25%, 8.34% and 5.45% respectively. They were more frequent in female students. The factors of anxiety (OR 1.07; 95% CI 0.99 to 1.16, P = 0.002) and depression (OR 0.55; 95% CI 0.15 to 1.05, P = 0.045) indicated a high risk of MK0683 price causing irritable bowel syndrome. Conclusion: Functional dyspepsia, irritable bowel syndrome and functional constipation were common in college and university students of North China. Psychological disorders such as anxiety and depression provide

significant risk factors for irritable bowel syndrome patients. Key Word(s): 1. functional dyspepsia; 2. prevalence; Presenting Author: JING TANG Additional Authors: JUN CHEN, YAN TAN Corresponding Author: JING TANG Affiliations: Affiliated hospital of Hainan medical college Objective: To evaluate the effects of various treatment on patients with functional dyspepsia (FD). Methods: 112 gastroenterology outpatients with FD, from March 2010 to June 2012, which were poor effect by conventional treatment of functional dyspepsia (FD) were randomly divided into 3 groups: A-group (n = 39), which received Deanxit, B-group (n = 32), control group, which was given conventional therapy (PPI or H2 receptor antagonists and the gastrointestinal motility drugs), C-group (n = 41), which was given Deanxit joint conventional treatment. The total course of was 8 weeks. Patients of 3 groups before and after Aspartate treatment were detected Self-Rating Anxiety Scale (SAS) and Self-Rating Depression Scale (SDS),

FD symptom score (FDSR), stomach accommodate test. Results: After treatment, the scores of SAS and SDS and the clinical symptom score dramatically decreased, and gastric accommodation improved gradually in treatment groups (group A and C). It shows significant difference (p < 0.01). Compared to the treatment group (group A and C) and the control group (B group) shows significant differences (p < 0.01). No significant side effects. Conclusion: To treat of FD, combined Deanxit with conventional medicine is the finest plan, with fast, save and efficacy. Key Word(s): 1. Deanxit; 2. Functional dyspepsia; 3. Therapeutic effect; Presenting Author: JING TANG Additional Authors: YAN TANG, JUN CHEN Corresponding Author: JING TANG Affiliations: Affiliated hospital of Hainan medical college Objective: To explore the psychological effect in patients with functional gastrointestinal disorders (FGIDs).